Blood volume (BV) can be calculated given the hematocrit (HC; the fraction of blood that is red blood cells) and plasma volume (PV), with the hematocrit being regulated via the blood oxygen content regulator:
Total Blood Volume can be measured manually via the Dual Isotope or Dual Tracer Technique, a classic technique, available since the 1950s. This technique requires double labeling of the blood; that is 2 injections and 2 standards (51Cr-RBC for tagging red blood cells and I-HAS for tagging plasma volume) as well as withdrawing and re-infusing patients with their own blood for blood volume analysis results. This method may take up to 6 hours for accurate results.
Blood volume may also be measured semi-automatically. The BVA-100, a product of Daxor Corporation, consists of an automated well counter interfaced with a computer. It is able to report Total Blood Volume (TBV), Plasma Volume (PV) and Red Cell Volume (RCV) using the indicator dilution principle, microhematocrit centrifugation and the Ideal Height and Weight Method. The indicator, or tracer, is an I-131 albumin injection. An equal amount of the tracer is injected into a known and unknown volume. Clinically, the unknown volume is the patient's blood volume, with the tracer having been injected into the patient's blood stream and tagged to the blood plasma. Once the tracer is injected a technician takes five blood samples which undergo microhematocrit centrifugation to extrapolate true blood volume at time 0. The concentration of the I-131 in the blood is determined from the blood radioactivity against the standard, which has a known I-131 dilution in a known volume. The unknown volume is inversely proportional to the concentration of the indicator in the known volume; the larger the unknown volume, the lower the tracer concentration, thus the unknown volume can be calculated. The microhematocrit data along with the I-131 indicator data provide a normalized hematocrit number, more accurate than hematocrit or peripheral hematocrit measurements. Measurements are taken 5 times at 6-minute intervals so that the BVA-100 can calculate the albumin transudation time to understand the flux of liquid through capillary membranes.
Blood volumes have also been measured in humans using the non-radioactive, carbon monoxide (CO) rebreathing technique for more than 100 years. With this technique, a small volume of pure CO gas is inhaled and rebreathed for a few minutes. During rebreathing, CO binds to hemoglobin present in red blood cells. Based on the increase in blood CO after the rebreathing period, the volume of blood can be determined through the dilution principle (i.e. similar as the case for radioactive tracer methods). Although CO gas in large volumes is toxic to humans, the volume used to access blood volumes corresponds to what would be inhaled when smoking one cigarette. While researchers typically use custom-made rebreathing circuits, the Detalo Performance from Detalo Health has fully automated the procedure and made the measurement available to a larger group of users.
|Guinea pig||75 (67-92)|